HPS Pharmacies wish to give notice that Merck Sharp & Dohme is experiencing a supply interruption for Emend® IV as follows:
Normal supplies are expected to resume in early January 2022. HPS Pharmacies has sourced an internationally registered alternative which may be accessed via the Special Access Scheme (SAS), if necessary. Please note that SAS alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Merck Sharp & Dohme on (02) 8988 8000 or your pharmacist at HPS Pharmacies.